The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer

Luise Fuhr, Rukeia El-Athman, Rosella Scrima, Olga Cela, Annalucia Carbone, Henning Knoop, Yin Li, Karen Hoffmann, Mikko O. Laukkanen, Francesco Corcione, Ralf Steuer, Thomas F. Meyer, Gianluigi Mazzoccoli, Nazzareno Capitanio, Angela Relógio

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

An endogenous molecular clockwork drives various cellular pathways including metabolism and the cell cycle. Its dysregulation is able to prompt pathological phenotypes including cancer. Besides dramatic metabolic alterations, cancer cells display severe changes in the clock phenotype with likely consequences in tumor progression and treatment response. In this study, we use a comprehensive systems-driven approach to investigate the effect of clock disruption on metabolic pathways and its impact on drug response in a cellular model of colon cancer progression. We identified distinctive time-related transcriptomic and metabolic features of a primary tumor and its metastatic counterpart. A mapping of the expression data to a comprehensive genome-scale reconstruction of human metabolism allowed for the in-depth functional characterization of 24 h-oscillating transcripts and pointed to a clock-driven metabolic reprogramming in tumorigenesis. In particular, we identified a set of five clock–regulated glycolysis genes, ALDH3A2, ALDOC, HKDC1, PCK2, and PDHB with differential temporal expression patterns. These findings were validated in organoids and in primary fibroblasts isolated from normal colon and colon adenocarcinoma from the same patient. We further identified a reciprocal connection of HKDC1 to the clock in the primary tumor, which is lost in the metastatic cells. Interestingly, a disruption of the core-clock gene BMAL1 impacts on HKDC1 and leads to a time-dependent rewiring of metabolism, namely an increase in glycolytic activity, as well as changes in treatment response. This work provides novel evidence regarding the complex interplay between the circadian clock and metabolic alterations in carcinogenesis and identifies new connections between both systems with pivotal roles in cancer progression and response to therapy.

Original languageEnglish
Pages (from-to)105-121
Number of pages17
JournalEBioMedicine
Volume33
DOIs
Publication statusPublished - Jul 1 2018

Fingerprint

Circadian Clocks
Tumors
Clocks
Colorectal Neoplasms
Phenotype
Metabolism
Pharmaceutical Preparations
Neoplasms
Genes
Colon
Carcinogenesis
Cells
Organoids
Glycolysis
Fibroblasts
Metabolic Networks and Pathways
Colonic Neoplasms
Cell Cycle
Adenocarcinoma
Therapeutics

Keywords

  • Circadian clock
  • Circadian regulation of metabolism
  • Colorectal cancer
  • Glycolysis
  • High-throughput circadian data
  • Metabolic network reconstruction
  • Metabolic rewiring
  • Treatment response
  • Tumor progression

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer. / Fuhr, Luise; El-Athman, Rukeia; Scrima, Rosella; Cela, Olga; Carbone, Annalucia; Knoop, Henning; Li, Yin; Hoffmann, Karen; Laukkanen, Mikko O.; Corcione, Francesco; Steuer, Ralf; Meyer, Thomas F.; Mazzoccoli, Gianluigi; Capitanio, Nazzareno; Relógio, Angela.

In: EBioMedicine, Vol. 33, 01.07.2018, p. 105-121.

Research output: Contribution to journalArticle

Fuhr, L, El-Athman, R, Scrima, R, Cela, O, Carbone, A, Knoop, H, Li, Y, Hoffmann, K, Laukkanen, MO, Corcione, F, Steuer, R, Meyer, TF, Mazzoccoli, G, Capitanio, N & Relógio, A 2018, 'The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer', EBioMedicine, vol. 33, pp. 105-121. https://doi.org/10.1016/j.ebiom.2018.07.002
Fuhr, Luise ; El-Athman, Rukeia ; Scrima, Rosella ; Cela, Olga ; Carbone, Annalucia ; Knoop, Henning ; Li, Yin ; Hoffmann, Karen ; Laukkanen, Mikko O. ; Corcione, Francesco ; Steuer, Ralf ; Meyer, Thomas F. ; Mazzoccoli, Gianluigi ; Capitanio, Nazzareno ; Relógio, Angela. / The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer. In: EBioMedicine. 2018 ; Vol. 33. pp. 105-121.
@article{c582777dabcb4725ab248b94d62149cc,
title = "The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer",
abstract = "An endogenous molecular clockwork drives various cellular pathways including metabolism and the cell cycle. Its dysregulation is able to prompt pathological phenotypes including cancer. Besides dramatic metabolic alterations, cancer cells display severe changes in the clock phenotype with likely consequences in tumor progression and treatment response. In this study, we use a comprehensive systems-driven approach to investigate the effect of clock disruption on metabolic pathways and its impact on drug response in a cellular model of colon cancer progression. We identified distinctive time-related transcriptomic and metabolic features of a primary tumor and its metastatic counterpart. A mapping of the expression data to a comprehensive genome-scale reconstruction of human metabolism allowed for the in-depth functional characterization of 24 h-oscillating transcripts and pointed to a clock-driven metabolic reprogramming in tumorigenesis. In particular, we identified a set of five clock–regulated glycolysis genes, ALDH3A2, ALDOC, HKDC1, PCK2, and PDHB with differential temporal expression patterns. These findings were validated in organoids and in primary fibroblasts isolated from normal colon and colon adenocarcinoma from the same patient. We further identified a reciprocal connection of HKDC1 to the clock in the primary tumor, which is lost in the metastatic cells. Interestingly, a disruption of the core-clock gene BMAL1 impacts on HKDC1 and leads to a time-dependent rewiring of metabolism, namely an increase in glycolytic activity, as well as changes in treatment response. This work provides novel evidence regarding the complex interplay between the circadian clock and metabolic alterations in carcinogenesis and identifies new connections between both systems with pivotal roles in cancer progression and response to therapy.",
keywords = "Circadian clock, Circadian regulation of metabolism, Colorectal cancer, Glycolysis, High-throughput circadian data, Metabolic network reconstruction, Metabolic rewiring, Treatment response, Tumor progression",
author = "Luise Fuhr and Rukeia El-Athman and Rosella Scrima and Olga Cela and Annalucia Carbone and Henning Knoop and Yin Li and Karen Hoffmann and Laukkanen, {Mikko O.} and Francesco Corcione and Ralf Steuer and Meyer, {Thomas F.} and Gianluigi Mazzoccoli and Nazzareno Capitanio and Angela Rel{\'o}gio",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.ebiom.2018.07.002",
language = "English",
volume = "33",
pages = "105--121",
journal = "EBioMedicine",
issn = "2352-3964",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer

AU - Fuhr, Luise

AU - El-Athman, Rukeia

AU - Scrima, Rosella

AU - Cela, Olga

AU - Carbone, Annalucia

AU - Knoop, Henning

AU - Li, Yin

AU - Hoffmann, Karen

AU - Laukkanen, Mikko O.

AU - Corcione, Francesco

AU - Steuer, Ralf

AU - Meyer, Thomas F.

AU - Mazzoccoli, Gianluigi

AU - Capitanio, Nazzareno

AU - Relógio, Angela

PY - 2018/7/1

Y1 - 2018/7/1

N2 - An endogenous molecular clockwork drives various cellular pathways including metabolism and the cell cycle. Its dysregulation is able to prompt pathological phenotypes including cancer. Besides dramatic metabolic alterations, cancer cells display severe changes in the clock phenotype with likely consequences in tumor progression and treatment response. In this study, we use a comprehensive systems-driven approach to investigate the effect of clock disruption on metabolic pathways and its impact on drug response in a cellular model of colon cancer progression. We identified distinctive time-related transcriptomic and metabolic features of a primary tumor and its metastatic counterpart. A mapping of the expression data to a comprehensive genome-scale reconstruction of human metabolism allowed for the in-depth functional characterization of 24 h-oscillating transcripts and pointed to a clock-driven metabolic reprogramming in tumorigenesis. In particular, we identified a set of five clock–regulated glycolysis genes, ALDH3A2, ALDOC, HKDC1, PCK2, and PDHB with differential temporal expression patterns. These findings were validated in organoids and in primary fibroblasts isolated from normal colon and colon adenocarcinoma from the same patient. We further identified a reciprocal connection of HKDC1 to the clock in the primary tumor, which is lost in the metastatic cells. Interestingly, a disruption of the core-clock gene BMAL1 impacts on HKDC1 and leads to a time-dependent rewiring of metabolism, namely an increase in glycolytic activity, as well as changes in treatment response. This work provides novel evidence regarding the complex interplay between the circadian clock and metabolic alterations in carcinogenesis and identifies new connections between both systems with pivotal roles in cancer progression and response to therapy.

AB - An endogenous molecular clockwork drives various cellular pathways including metabolism and the cell cycle. Its dysregulation is able to prompt pathological phenotypes including cancer. Besides dramatic metabolic alterations, cancer cells display severe changes in the clock phenotype with likely consequences in tumor progression and treatment response. In this study, we use a comprehensive systems-driven approach to investigate the effect of clock disruption on metabolic pathways and its impact on drug response in a cellular model of colon cancer progression. We identified distinctive time-related transcriptomic and metabolic features of a primary tumor and its metastatic counterpart. A mapping of the expression data to a comprehensive genome-scale reconstruction of human metabolism allowed for the in-depth functional characterization of 24 h-oscillating transcripts and pointed to a clock-driven metabolic reprogramming in tumorigenesis. In particular, we identified a set of five clock–regulated glycolysis genes, ALDH3A2, ALDOC, HKDC1, PCK2, and PDHB with differential temporal expression patterns. These findings were validated in organoids and in primary fibroblasts isolated from normal colon and colon adenocarcinoma from the same patient. We further identified a reciprocal connection of HKDC1 to the clock in the primary tumor, which is lost in the metastatic cells. Interestingly, a disruption of the core-clock gene BMAL1 impacts on HKDC1 and leads to a time-dependent rewiring of metabolism, namely an increase in glycolytic activity, as well as changes in treatment response. This work provides novel evidence regarding the complex interplay between the circadian clock and metabolic alterations in carcinogenesis and identifies new connections between both systems with pivotal roles in cancer progression and response to therapy.

KW - Circadian clock

KW - Circadian regulation of metabolism

KW - Colorectal cancer

KW - Glycolysis

KW - High-throughput circadian data

KW - Metabolic network reconstruction

KW - Metabolic rewiring

KW - Treatment response

KW - Tumor progression

UR - http://www.scopus.com/inward/record.url?scp=85049588993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049588993&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2018.07.002

DO - 10.1016/j.ebiom.2018.07.002

M3 - Article

C2 - 30005951

AN - SCOPUS:85049588993

VL - 33

SP - 105

EP - 121

JO - EBioMedicine

JF - EBioMedicine

SN - 2352-3964

ER -